You may receive the study drug for up to 2 years. At that point, you may be allowed to continue taking the study drug for as long as the sponsor provides the drug and the doctor thinks it is in your best interest. You will no longer be able to take the study drug if the disease gets worse, if intolerable side effects occur, or if you are unable to follow study directions.